The Skin Structure Infections market is a segment of the Infectious Diseases Drugs market. It includes drugs used to treat bacterial infections of the skin and underlying tissue, such as cellulitis, impetigo, and abscesses. These drugs are typically antibiotics, antifungals, or antivirals, and may be administered orally, intravenously, or topically. Treatment of skin structure infections is important to prevent the spread of infection to other parts of the body, and to reduce the risk of complications. The Skin Structure Infections market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, AstraZeneca, Johnson & Johnson, and Bayer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
